Azacitidine in the treatment of extramedullary relapse of AML after allogeneic hematopoietic cell transplantation

被引：0
|
作者：
A Antar
Z K Otrock
M Kharfan-Dabaja
Z Salem
S Aractingi
M Mohty
A Bazarbachi
机构：
[1] American University of Beirut Medical Center,Department of Internal Medicine
[2] Leukemia Program,Department of Blood and Marrow Transplantation
[3] Taussig Cancer Institute,Department of Dermatology
[4] Cleveland Clinic,undefined
[5] Moffitt Cancer Center,undefined
[6] Tenon Hospital,undefined
[7] APHP and Paris 6 University,undefined
[8] Hematologie Clinique,undefined
[9] Université de Nantes and INSERM CRNCA UMR892,undefined
来源：
Bone Marrow Transplantation | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：994 / 995
页数：1
相关论文
共 50 条
  • [1] Azacitidine in the treatment of extramedullary relapse of AML after allogeneic hematopoietic cell transplantation
    Antar, A.
    Otrock, Z. K.
    Kharfan-Dabaja, M.
    Salem, Z.
    Aractingi, S.
    Mohty, M.
    Bazarbachi, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 (07) : 994 - 995
  • [2] Very late relapse of AML after allogeneic hematopoietic cell transplantation is often extramedullary
    J M Watts
    X V Wang
    R T Swords
    E Paietta
    D Douer
    S M Lugar
    H F Fernandez
    J M Rowe
    H M Lazarus
    M S Tallman
    M R Litzow
    Bone Marrow Transplantation, 2016, 51 : 1013 - 1015
  • [3] Very late relapse of AML after allogeneic hematopoietic cell transplantation is often extramedullary
    Watts, J. M.
    Wang, X. V.
    Swords, R. T.
    Paietta, E.
    Douer, D.
    Lugar, S. M.
    Fernandez, H. F.
    Rowe, J. M.
    Lazarus, H. M.
    Tallman, M. S.
    Litzow, M. R.
    BONE MARROW TRANSPLANTATION, 2016, 51 (07) : 1013 - 1015
  • [4] Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML
    El Chaer, Firas
    Borate, Uma
    Dulery, Remy
    Holtan, Shernan G.
    Law, Arjun Datt
    Muffly, Lori
    Nassereddine, Samah
    Shallis, Rory M.
    Stringaris, Kate
    Taylor, Justin
    Devine, Steven M.
    Mohty, Mohamad
    Hourigan, Christopher S.
    BLOOD ADVANCES, 2021, 5 (06) : 1757 - 1759
  • [5] Treatment of AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Using Low-Dose Azacitidine (AZA)
    Chiattone, Alexandre
    Saliba, Rima M.
    Andersson, Borje S.
    Giralt, Sergio
    Sharma, Manish R.
    Rondon, Gabriela
    Kebriaei, Partow
    Hosing, Chitra
    Popat, Uday
    Parmar, Simrit
    Alatrash, Gheath
    Bashir, Qaiser
    Chen, Julianne J.
    Yuen, Carrie Hai-Lai
    Chiattone, Viviane C.
    Champlin, Richard E.
    De Lima, Marcos
    BLOOD, 2010, 116 (21) : 1413 - 1413
  • [6] Treatment of Recurrent or Persistent AML/MDS After Allogeneic Hematopoietic Cell Transplantation with Azacitidine.
    Vaughn, Jennifer
    Storer, Barry
    Mielcarek, Marco
    Warren, Edus H., III
    Martin, Paul J.
    Sandmaier, Brenda M.
    Estey, Elihu H.
    Storb, Rainer
    Deeg, H. Joachim
    Scott, Bart Lee
    BLOOD, 2010, 116 (21) : 551 - 551
  • [7] Gemtuzumab Ozogamicin Therapy for Isolated Extramedullary AML Relapse after Allogeneic Hematopoietic Stem-Cell Transplantation
    Ando, Toshihiko
    Mitani, Noriyuki
    Matsunaga, Kimie
    Nakazora, Tatsuki
    Gondo, Toshikazu
    Yujiri, Toshiaki
    Tanizawa, Yukio
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 220 (02): : 121 - 125
  • [8] Pathogenesis of relapse after allogeneic hematopoietic transplantation for AML
    Sierra, Jorge
    Carreras, Jose
    BONE MARROW TRANSPLANTATION, 2018, 53 : 810 - 811
  • [9] Editorial: The Elephant in the Room: AML Relapse After Allogeneic Hematopoietic Cell Transplantation
    Battipaglia, Giorgia
    Saraceni, Francesco
    Malard, Florent
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Extramedullary relapse of leukemia after allogeneic hematopoietic stem cell transplantation A retrospective study
    Xie, Ning
    Zhou, Jian
    Zhang, Yanli
    Yu, Fengkuan
    Song, Yongping
    MEDICINE, 2019, 98 (19)
12345